Search Results - "Katzman, PL"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Renal and endocrine effects of long-term converting enzyme inhibition as compared with calcium antagonism in essential hypertension by Katzman, P L, Henningsen, N C, Fagher, B, Thulin, T, Hulthén, U L

    Published in Journal of cardiovascular pharmacology (01-03-1990)
    “…In a double-blind, double-dummy, placebo-controlled crossover design, the renal hemodynamic and tubular effects of 2-month specific vasodilation with a…”
    Get more information
    Journal Article
  2. 2

    Use of anabolic-androgenic steroids among body builders--frequency and attitudes by Lindström, M, Nilsson, A L, Katzman, P L, Janzon, L, Dymling, J F

    Published in Journal of internal medicine (01-06-1990)
    “…A total of 138 male body builders who regularly attended a gym participated anonymously in a study of the use of anabolic-androgenic steroids in relation to…”
    Get more information
    Journal Article
  3. 3

    Renal effects of acute and long-term treatment with felodipine in essential hypertension by Hulthén, U L, Katzman, P L

    Published in Journal of hypertension (01-03-1988)
    “…Enhanced renal vasoconstriction and renal tubular sodium reabsorption mediated by noradrenaline and angiotensin II (Ang II) have been implicated in the…”
    Get more information
    Journal Article
  4. 4

    Serum lipid profile determines platelet reactivity to native and modified LDL-cholesterol in humans by Katzman, P L, Bose, R, Henry, S, McLean, D L, Walker, S, Fyfe, C, Perry, Y, Mymin, D, Bolli, P

    Published in Thrombosis and haemostasis (01-05-1994)
    “…The effects of thrombin (0.2 U/ml) and native (n-LDL), malondialdehyde-modified (MDA-LDL) and auto-oxidized (ox-LDL) low-density lipoproteins (20 micrograms of…”
    Get more information
    Journal Article
  5. 5

    Acute renal tubular and hemodynamic effects of the calcium antagonist felodipine in healthy volunteers by Katzman, P L, DiBona, G F, Hökfelt, B, Hulthén, U L

    “…To evaluate the renal tubular effects of felodipine in a low (1.25-mg) and a high (10-mg) dose, lithium clearance was measured and related to renal…”
    Get full text
    Journal Article
  6. 6

    Temperature-dependence of LDL binding and activation of human platelets by Katzman, P L, Bose, R, Walker, S, Perry, Y, Bolli, P

    Published in Thrombosis research (15-11-1991)
    “…The effect of low density lipoprotein (LDL) on intracellular free calcium ion concentration ([Ca2+]i), taken as an index of the degree of platelet activation,…”
    Get more information
    Journal Article
  7. 7

    The effect of 8 weeks treatment with the calcium antagonist felodipine on blood pressure, heart rate, working capacity, plasma renin activity, plasma angiotensin II, urinary catecholamines and aldosterone in patients with essential hypertension by Katzman, PL, Hulthen, UL, Hokfelt, B.

    Published in British journal of clinical pharmacology (01-06-1986)
    “…The effect of 8 weeks treatment with the calcium antagonist felodipine‐ a new long‐acting dihydropyridine derivative‐in a dose of 10 mg twice daily was studied…”
    Get full text
    Journal Article
  8. 8

    Amiloride compared with nitrendipine in treatment of essential hypertension by Katzman, P L, Henningsen, N C, Hulthén, U L

    Published in Journal of human hypertension (01-10-1988)
    “…The antihypertensive effect of amiloride was compared to that of the calcium antagonist nitrendipine in 12 patients (8 males), aged 34-62 years, with essential…”
    Get more information
    Journal Article
  9. 9

    Catecholamines, renin-angiotensin-aldosterone, and cardiovascular response during exercise following acute and long-term calcium antagonism with felodipine in essential hypertension by Katzman, P L, Hulthén, U L, Hökfelt, B

    Published in Journal of cardiovascular pharmacology (01-10-1987)
    “…Studies were performed in nine patients with essential hypertension to explore the effect of the calcium antagonist felodipine on the exercise-induced…”
    Get more information
    Journal Article
  10. 10

    Review of long-term trials with nitrendipine by Hulthén, U L, Katzman, P L

    “…The dihydropyridine calcium antagonist nitrendipine offers a pathophysiologically based antihypertensive treatment with a potent dilation of resistance…”
    Get more information
    Journal Article
  11. 11

    Serum gonadotropins in postmenopausal women after long-term verapamil treatment by Hulthén, U L, Katzman, P L

    “…The effect of long-term verapamil treatment on serum gonadotropin levels was studied in 13 postmenopausal women aged 48-73 years given verapamil 160-320 mg…”
    Get more information
    Journal Article
  12. 12

    Unchanged insulin secretion and glucose tolerance but increased insulin clearance during long-term calcium antagonism with felodipine in essential hypertension by Katzman, P L, Hulthén, U L, Hökfelt, B

    Published in Hormone and metabolic research (01-09-1987)
    “…Studies were performed to explore the effect of calcium antagonism with felodipine for 8 weeks on glucose homeostasis and serum lipids in 8 patients with…”
    Get more information
    Journal Article
  13. 13

    Effects of the calcium antagonist felodipine on the sympathetic and renin-angiotensin-aldosterone systems in essential hypertension by Katzman, P L, Hulthén, U L, Hökfelt, B

    Published in Acta medica Scandinavica (01-01-1988)
    “…Studies were performed in 10 male patients with untreated essential hypertension, WHO grade I-II, aged 25-62 years, to explore the acute (single dose) and…”
    Get more information
    Journal Article